ANHYDRIX
Live / Applied — Fifth extension granted (statement of use) (as of 26 Jan 2026)
What this means for you
Not registered yet, but its 19 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97419330
- Mark type
- Stylized text
- Filed
- 19 May 2022
- Published for opposition
- 23 May 2023
- Attorney of record
- Bret E. Field
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic compositions containing oxybutynin and pilocarpine for medicinal use in connection with the treatment of hyperhidrosis; Pharmaceutical preparations, namely, compositions containing oxybutynin and pilocarpine for use in the treatment of hyperhidrosis
Owner
- TheraVida, Inc., Chapel Hill, NC, US
- TheraVida, Inc., Chapel Hill, NC, US
Prosecution history
- 26 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — SOU EXTENSION 5 GRANTED
- 14 Jan 2026 — SOU EXTENSION 5 FILED
- 15 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2025 — SOU EXTENSION 4 GRANTED
- 14 Jul 2025 — SOU EXTENSION 4 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2025 — SOU EXTENSION 3 GRANTED
- 21 Jan 2025 — SOU EXTENSION 3 FILED
- 21 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2024 — SOU EXTENSION 2 GRANTED
- 12 Jul 2024 — SOU EXTENSION 2 FILED